Stimulus funds force hard look at comparative effectiveness research.
Tuma
Rabiya S
RS
D014408:Biomarkers, Tumor / Q000378:metabolism; D035843:Biomedical Research / Q000191:economics / Q000639:trends; D004345:Drug Industry / Q000639:trends*; D035082:Federal Government; D005380:Financing, Government; D006801:Humans; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000188:drug therapy / Q000191:economics / Q000378:metabolism; D018579:Patient Selection; D012109:Research Support as Topic; D016896:Treatment Outcome; D014481:United States
D014408:Biomarkers, Tumor